Skip to main content
. 2022 Feb 17;8(2):e08980. doi: 10.1016/j.heliyon.2022.e08980

Table 2.

Hematological parameters before and after treatment of the patients (n = 44).

Hematological parameters IV Iron Sucrose
Blood transfusion
Baseline, n = 22 After 6 weeks, n = 22 p-value Baseline, n = 22 After 6 weeks, n = 22 p-value
Hemoglobin (g/dl) 7.4 (0.32) 11.6 (1.0) 0.001 7.3 (0.31) 11.8 (1.2) 0.001
Serum ferritin (μg/l) 73.5 (3.0) 114 (2.5) 0.001 73.2 (3.0) 118 (3.6) 0.001
Reticulocyte count (%) 1.50 (0.60) 5.1 (1.3) 0.001 1.60 (0.80) 5.5 (1.8) 0.001
MCV (fl) 67.24 (5.0) 84 (1.4) 0.001 69.20 (3.0) 85 (2.3) 0.001
MCH (pg) 22.3 (2.6) 44 (3.2) 0.001 23.2 (3.6) 45 (3.1) 0.001
MCHC (g/dl) 26.5 (1.9) 54 (1.5) 0.001 26.7 (1.2) 56 (2.5) 0.001